Global Renal Replacement and ESRD Therapy Market Growth (Status and Outlook) 2025-2031

The global Renal Replacement and ESRD Therapy market size is predicted to grow from US$ 109790 million in 2025 to US$ 145230 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.

Renal replacement therapy (RRT) is therapy that replaces the normal blood-filtering function of the kidneys. It is used when the kidneys are not working well, which is called kidney failure and includes acute kidney injury and chronic kidney disease. Renal replacement therapy includes dialysis (hemodialysis or peritoneal dialysis), hemofiltration, and hemodiafiltration, which are various ways of filtration of blood with or without machines. Renal replacement therapy also includes kidney transplantation, which is the ultimate form of replacement in that the old kidney is replaced by a donor kidney.

The Renal Replacement and End-Stage Renal Disease (ESRD) Therapy market is primarily driven by the increasing prevalence of chronic kidney diseases and the growing demand for effective treatment options. Renal replacement therapies, including hemodialysis, peritoneal dialysis, and kidney transplantation, play a vital role in managing ESRD, a condition characterized by kidney function decline to a point where life-sustaining treatment is necessary. The rising global burden of ESRD and the need for improved patient outcomes contribute to market growth as healthcare systems seek advanced therapies that offer enhanced dialysis efficiency, patient comfort, and reduced treatment-related complications. Moreover, technological advancements in dialysis equipment, access to kidney transplants, and remote patient monitoring align with improved therapeutic options, fostering market adoption. However, the market also faces challenges, including the high cost of dialysis procedures, limited availability of organ donors, and concerns related to infection risk in immunocompromised patients. Additionally, addressing regulatory compliance, patient education, and disparities in access to care can pose obstacles for healthcare providers and manufacturers. To succeed, stakeholders must focus on innovation in therapy delivery, affordability, and addressing the challenges to provide patients with comprehensive renal replacement options that enhance their quality of life and contribute to better management of ESRD.

LPI (LP Information)' newest research report, the “Renal Replacement and ESRD Therapy Industry Forecast” looks at past sales and reviews total world Renal Replacement and ESRD Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Renal Replacement and ESRD Therapy sales for 2025 through 2031. With Renal Replacement and ESRD Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Renal Replacement and ESRD Therapy industry.

This Insight Report provides a comprehensive analysis of the global Renal Replacement and ESRD Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Renal Replacement and ESRD Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Renal Replacement and ESRD Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Renal Replacement and ESRD Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Renal Replacement and ESRD Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Renal Replacement and ESRD Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:
Devices
Consumables
Services

Segmentation by Application:
Hospital
Dialysis Center
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Fresenius
DaVita
Baxter
US rental care
B.Braun
Diaverum
Nipro
Asahi Kasei
Nikkiso
Toray
WEGO
JMS
Medtronic
SWS Hemodialysis Care

Please note: The report will take approximately 2 business days to prepare and deliver.